ALX vs JNJ · P/E 63, rev $108.1M vs P/E 17, rev $49.37B
Alexanders Inc (ALX) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Alexanders Inc (ALX) is a reit - retail company listed on NYSE.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported ALX revenue for 2026-06-30 was $108.1M. Net income was $160.0M. ALX currently screens at market cap $1.30B and trailing P/E 63.5.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
ALX currently screens at market cap $1.30B and trailing P/E 63.5. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the ALX and JNJ stock pages for the full models.
Not investment advice.